相关实验视频
Updated: Jan 16, 2026

12:08
Diagonal Method to Measure Synergy Among Any Number of Drugs
Published on: June 21, 2018
19.5K
CADS:一种因果推理框架,用于识别必要的基因,以增强药物协同效应预测
Huaiwu Zhang1, Xinliang Sun2, Jianxin Wang2
1Research Program in Systems Oncology, Faculty of Medicine, University of Helsinki, Helsinki, 02600, Finland.
Bioinformatics (Oxford, England)
|January 15, 2026
概括
我们开发了CADS,这是一个深度学习框架,通过整合因果基因与药物反应关系来预测药物协同作用. 这种方法通过可解释的因果基因发现来增强组合疗法开发,并优于现有的方法.
科学领域:
- 计算生物学 计算生物学
- 药物基因组学 药物基因组学
- 人工智能在医学中的应用
背景情况:
- 传统的药物协同作用查是低效和昂贵的.
- 目前用于药物协同作用的深度学习模型缺乏因果基因药物反应建模.
- 预测协同药物组合对于有效的组合疗法至关重要.
研究的目的:
- 提出CADS (药物协同因果调整),一个新的深度学习框架.
- 整合因果基因与药物反应关系,以预测协同效应.
- 在药物开发中实现可解释的因果基因发现.
主要方法:
- 利用多主题数据和因果推理原则.
- 使用可学习的掩护机制来识别关键的因果基因.
- 应用后门调整来过不相关的遗传因素.
主要成果:
- CADS准确地预测药物协同作用,并发现可解释的因果基因.
- 该框架在多个指标上始终优于最先进的方法.
- 案例研究显示,CADS识别了经过临床验证的癌症基因,可以调解药物相互作用.
结论:
- 通过模拟药物协同作用的因果基因,CADS推进了组合疗法预测.
- 该框架为人工智能驱动的药物开发提供了更好的解释性.
- 通过基因重要性得分,CADS提供了宝贵的生物学见解.
相关概念视频
Drug Discovery: Overview
11.0K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
11.0K
Combined Effects of Drugs: Synergism
6.7K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
6.7K
Structure-Activity Relationships and Drug Design
1.7K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.7K
Factors Affecting Drug Response: Overview
3.0K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
3.0K
Agonism and Antagonism: Quantification
975
When drugs are administered, they can elicit either an agonist or antagonist effect on the body. Agonism occurs when a drug activates a specific receptor, triggering a biological response. On the other hand, antagonism happens when a drug binds to the same receptors but blocks their activation, thereby preventing a biological response.
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
975
Genome-wide Association Studies-GWAS
15.3K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
15.3K

